FindTrial
Sign In

Immune and ultrasound contrasted evaluation for hepatic alveolar echinococcosis after chemotherapy and surgery

Immune and ultrasound contrasted evaluation for hepatic alveolar echinococcosis after chemotherapy and surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCS-14004579
Enrollment
Unknown
Registered
2014-03-12
Start date
2014-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic alveolar echinococcosis

Interventions

case series:NA

Sponsors

First Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Without limit on sex, nation and occupation; All patients with hepatic alveolar echinococcosis had diagnosed by imaging; hydatid serum test showed positive; Patients want to join this research with their own accord.

Exclusion criteria

Exclusion criteria: Patients with one or multiple organs'failure involved; Patients who don't want to join this research with their own accord; Patients with malignant tumor or other diseases which could have an effect on result Such as autoimmune disease involved; Some situation would endanger life of patients in the period of research.

Design outcomes

Primary

MeasureTime frame
INF-?;IL-10;IL-5;Ultrasound contrast;Ultrasound contrast;vascular endothelial growth factor,VEGF;microvascular dentify, MVD;—

Countries

China

Contacts

Public ContactLi Hai-tao

First Affiliated Hospital of Xinjiang Medical University

lht45182@163.com+86 13899812351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026